Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

MRNA – Moderna, Inc.

Moderna, Inc.
MRNA
$27.46
Name : Moderna, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $10,619,935,744.00
EPSttm : -8.73
finviz dynamic chart for MRNA
Moderna, Inc.
$27.46
5.13%
$1.34

Float Short %

19.64

Margin Of Safety %

Put/Call OI Ratio

0.69

EPS Next Q Diff

0.71

EPS Last/This Y

-0.76

EPS This/Next Y

2.69

Price

27.45

Target Price

43.9

Analyst Recom

2.86

Performance Q

-22.89

Relative Volume

0.78

Beta

1.86

Ticker: MRNA




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-08MRNA24.360.700.22880335
2025-05-09MRNA24.250.660.31911262
2025-05-12MRNA25.730.710.52849948
2025-05-13MRNA25.50.690.52873845
2025-05-14MRNA24.030.690.84877119
2025-05-15MRNA23.640.690.41889704
2025-05-16MRNA24.850.680.31903244
2025-05-19MRNA26.410.720.21821185
2025-05-20MRNA27.990.680.37881623
2025-05-21MRNA25.810.680.73954403
2025-05-22MRNA26.720.670.38961603
2025-05-23MRNA26.260.670.19976398
2025-05-27MRNA26.750.690.36895850
2025-05-28MRNA26.060.670.64921339
2025-05-29MRNA26.920.671.20930533
2025-05-30MRNA26.590.680.20940587
2025-06-02MRNA27.060.700.74912937
2025-06-03MRNA27.810.700.29928737
2025-06-04MRNA27.260.680.67951548
2025-06-05MRNA26.080.680.44959743
2025-06-06MRNA27.450.690.16990578
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-08MRNA24.3711.0-968.2-10.12
2025-05-09MRNA24.2511.0-794.0-10.12
2025-05-12MRNA25.7011.0-1410.7-10.12
2025-05-13MRNA25.4911.0-770.6-10.12
2025-05-14MRNA24.0111.0-320.5-10.12
2025-05-15MRNA23.6511.0-691.8-10.12
2025-05-16MRNA24.8711.0-1353.0-10.11
2025-05-19MRNA26.3911.0-1413.9-10.11
2025-05-20MRNA27.9911.0-1369.7-10.11
2025-05-21MRNA25.8311.0-211.3-10.11
2025-05-22MRNA26.7311.0-1163.2-10.11
2025-05-23MRNA26.2811.8-701.9-10.04
2025-05-27MRNA26.7611.8-1009.1-10.04
2025-05-28MRNA26.0511.8-615.1-10.04
2025-05-29MRNA26.9311.8-1140.4-10.04
2025-05-30MRNA26.5611.8-726.0-10.04
2025-06-02MRNA27.0611.8-1005.0-10.04
2025-06-03MRNA27.8111.8-1080.8-10.04
2025-06-04MRNA27.2511.8-679.1-10.04
2025-06-05MRNA26.1211.8-489.2-10.04
2025-06-06MRNA27.4511.8-1289.8-10.04
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-08MRNA0.438.9116.44
2025-05-09MRNA0.438.9116.44
2025-05-12MRNA0.433.9317.58
2025-05-13MRNA0.433.9317.58
2025-05-14MRNA0.433.9317.58
2025-05-15MRNA0.423.9317.62
2025-05-16MRNA0.423.9317.62
2025-05-19MRNA0.425.2817.58
2025-05-20MRNA0.435.2817.58
2025-05-21MRNA0.435.2817.58
2025-05-22MRNA0.435.2817.58
2025-05-23MRNA0.435.2817.58
2025-05-27MRNA0.431.0917.58
2025-05-28MRNA0.431.0919.64
2025-05-29MRNA0.431.0919.64
2025-05-30MRNA0.431.0919.64
2025-06-02MRNA0.431.4019.64
2025-06-03MRNA0.431.4019.64
2025-06-04MRNA0.431.4019.64
2025-06-05MRNA0.431.4019.64
2025-06-06MRNA0.431.4019.64
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-2.52

Avg. EPS Est. Current Quarter

-2.95

Avg. EPS Est. Next Quarter

-1.81

Insider Transactions

0.43

Institutional Transactions

1.4

Beta

1.86

Average Sales Estimate Current Quarter

116

Average Sales Estimate Next Quarter

1155

Fair Value

Quality Score

42

Growth Score

39

Sentiment Score

9

Actual DrawDown %

94.5

Max Drawdown 5-Year %

-95.1

Target Price

43.9

P/E

Forward P/E

PEG

P/S

3.34

P/B

1.06

P/Free Cash Flow

EPS

-8.72

Average EPS Est. Cur. Y​

-10.04

EPS Next Y. (Est.)

-7.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-105.67

Relative Volume

0.78

Return on Equity vs Sector %

-57.4

Return on Equity vs Industry %

-39.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

-1289.8
Moderna, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 5800
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
stock quote shares MRNA – Moderna, Inc. Stock Price stock today
news today MRNA – Moderna, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MRNA – Moderna, Inc. yahoo finance google finance
stock history MRNA – Moderna, Inc. invest stock market
stock prices MRNA premarket after hours
ticker MRNA fair value insiders trading